SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling
2005

Gene Expression Changes in Colon Cancer Cells Treated with SN-38

Sample size: 192 publication Evidence: moderate

Author Information

Author(s): Vinicius Souza, Dong Yan Bin, Zhou H Sam, Zacharias Wolfgang, McMasters Kelly M

Primary Institution: University of Louisville School of Medicine

Hypothesis

The study aims to evaluate changes in gene expression in SW-620 cells in response to SN-38 to understand its mechanisms of inducing apoptosis and cell cycle arrest.

Conclusion

The study enhances understanding of the biochemical pathways involved in SN-38-induced apoptosis and may help identify new therapeutic targets.

Supporting Evidence

  • 192 genes showed over a 2-fold change in expression after SN-38 treatment.
  • Most affected genes were related to DNA replication, transcription, signal transduction, and apoptosis.
  • 14 genes' expression changes were confirmed by quantitative real-time PCR.

Takeaway

This study looked at how a cancer drug called SN-38 changes the way certain genes work in cancer cells, which helps us understand how it can kill those cells.

Methodology

The study used a quantitative gene expression microarray assay and confirmed results with RT-PCR to analyze gene expression changes in SW-620 colon cancer cells after SN-38 treatment.

Statistical Information

P-Value

<0.006

Statistical Significance

p<0.006

Digital Object Identifier (DOI)

10.1186/1479-5876-3-44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication